Search Results | American Association of Immunologists

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Improving immunotherapeutic efficacy against metastatic tumors in a pre-clinical model of murine renal cell carcinoma.

Shannon Kathryn Boi, Rachael M Orlandella, Lyse A Norian

J Immunol (2017) 198 (1_Supplement): 79.9.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.9

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Dendritic cell CD40 targeting vaccines elicit CD8⁺ T cell-mediated therapeutic immunity against cancers

Wenjie Yin, Dorothée Duluc, HyeMee Joo, Yaming Xue, Chao Gu, Zhiqing Wang, Lei Wang, Lance Oxford, Amelia Clark, Falguni Parikh, LuAnn Thompson-Snipes, Jung-Hee Woo, Sandra Zurawski, Andrew G Sikora, Gerard Zurawski, SangKon Oh

J Immunol (2017) 198 (1_Supplement): 79.8.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.8

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Blocking CD13 in combination with a toll like receptor agonist increases the efficacy of cancer vaccine adjuvants

Veneta Qendro, Mallika Ghosh, Linda Shapiro

J Immunol (2017) 198 (1_Supplement): 79.26.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.26

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Efficacy of combining radiotherapy and immunotherapy for metastatic colorectal cancer and the modulation of tumor microenvironment

Chia-Jen Wu, Yi-Ting Tsai, Ching-Cheng Chang, I-Jung Lee, Ping-Yi Wu, Mi-Hua Tao

J Immunol (2017) 198 (1_Supplement): 79.15.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.15

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Harnessing innate anti-tumour immunity using a Klebsiella-derived therapeutic to reduce tumour burden and improve outcomes in mouse models of lung cancer

Mark Bazett, Amanda L Costa, Momir Bosiljcic, Matthew P Alexander, Rebecca M Anderson, Stephanie WY Wong, Hal Gunn, Shirin Kalyan, David W Mullins

J Immunol (2017) 198 (1_Supplement): 79.33.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.33

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Engineering of novel Class II Transactivator gene delivery systems as molecular adjuvants to improve genetic immunotherapies by inducing de novo MHC II expression in human cells

Mariana de Lucena Palma, Parichat Duangkhae, Bruno Douradinha, Rafael Dhalia, Robbie B Mailliard, Simon Barratt-Boyes, Telma Miyuki Oshiro, Ernesto Torres de Azevedo Marques, Alberto José da Silva Duarte

J Immunol (2017) 198 (1_Supplement): 79.16.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.16

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

The cytotoxic formulation, INT230-6, induces protective T cell immunity

Anja Bloom, Lewis H Bender, Ian B Walters, Katharine T Clark, Masaki Terabe, Jay A Berzofsky

J Immunol (2017) 198 (1_Supplement): 79.10.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.10

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Genetic linkage analysis of cancer vaccine response in Diversity Outbred mice

Heather Gibson, Joyce Reyes, Richard Jones, Greg Dyson, Wei-Zen Wei

J Immunol (2017) 198 (1_Supplement): 79.29.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.29

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Controlled release of mTOR inhibitors to enhance CD8⁺ T cell memory

Qin Zeng, Christopher M Jewell

J Immunol (2017) 198 (1_Supplement): 79.17.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.17

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Radiation Therapy and Talimogene Laherparepvec (TVEC) Synergize in the Treatment of Melanoma

Sachin R Jhawar, Sharad Goyal, Aditya Thandoni, Praveen Bommareddy, Suemair Hassan, Devora Schiff, Bruce G Haffty, Howard Kaufman, Andrew Zloza

J Immunol (2017) 198 (1_Supplement): 79.32.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.32

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Tumor Lysate Loaded Dendritic Cells Induce a T cell Specific Antitumor Response Against Gallbladder Cancer

Daniel Alberto Rojas-Sepúlveda, Mª Alejandra Gleisner, Cristian Pereda, Mercedes López, Flavio Salazar-Onfray

J Immunol (2017) 198 (1_Supplement): 79.18.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.18

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

CD11c⁺ MHCII^int bone marrow-derived dendritic cells as adjuvants for neoepitope – based cancer immunotherapy

Hakimeh Ebrahimi-Nik, William L. Corwin, Ryo Yamamoto, Pramod K Srivastava

J Immunol (2017) 198 (1_Supplement): 79.14.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.14

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

RNAdjuvant^®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile

Johannes Lutz, Regina Heidenreich, Keyvan Tadjalli Mehr, Janine Noth, Sven D Koch, Fatma Döner, Henoch S Hong, Karl Melber, Angelika Dähling, Tilmann Roos, Aleksandra Kowalczyk, Patrick Baumhof, Birgit Scheel, Söhnke Voss, Karl-Josef Kallen, Mariola Fotin-Mleczek, Ulrike Gnad-Vogt

J Immunol (2017) 198 (1_Supplement): 79.7.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.7

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Pro-inflammatory properties of orally delivered calcium-encapsulated CpG Oligodeoxynucleotides

Neslihan Kayraklioglu, Katherine H Parker, Julia Scheiermann, Dennis M Klinman

J Immunol (2017) 198 (1_Supplement): 79.6.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.6

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

HER-2+ breast cancer cells expressing GPI-anchored cytokines induce long lasting antitumor memory response

Luis E Munoz, Ramireddy Bommireddy, Camilla Margaroli, Yalda Shafizadeh, Erica N Bozeman, Ashwathi P Menon, Jayanth Kumar, Ramana Lakshmanan, Periasamy Selvaraj

J Immunol (2017) 198 (1_Supplement): 79.28.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.28

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Enhancement of antigen presentation of a vaccine with the use of human anti-rhamnose antibody both in-vitro and in-vivo

Md Kamal Hossain, Abhishek Vartak, Partha Karmakar, Steven J. Sucheck, Katherine Ann Wall

J Immunol (2017) 198 (1_Supplement): 79.19.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.19

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Analysis of immunogenicity of different sizes of HER2/neu antigen

Insu Jeon, Hyungseok Seo, Myung Hwan Park, Kwang-Soo Shin, Jeong-mi Lee, Jeongwon Choi, Boyeong Song, Choong-Hyun Koh, Eun-Ah Bae, Chang-Yuil Kang

J Immunol (2017) 198 (1_Supplement): 79.5.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.5

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Probing changes to local and systemic immunity following intranodal injection

James I Andorko, Joshua M Gammon, Christopher M Jewell

J Immunol (2017) 198 (1_Supplement): 79.4.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.4

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

New strategies in vaccine design for the induction of CD8 T cell responses using biodegradable iron oxide nanoparticles

Liam M Powles, Kirsty Wilson, Sue D Xiang, Cordelia Selomulya, Magdalena Plebanski

J Immunol (2017) 198 (1_Supplement): 79.23.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.23

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Activation of the TLR2-MyD88 pathway is required for in-vivo efficacy of Lipid Nanoparticle based vaccine formulation

Gokul Swaminathan, Shu-An Lin, ManishKumar Patel, Katie DiFelice, Jeffrey Smith, Marian Gindy, Ashley Mahne, Daniel Cua, Danilo Casimiro, Amy Espeseth, Andrew Bett

J Immunol (2017) 198 (1_Supplement): 79.2.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.79.2

Published: 01 May 2017

View article

Add to Citation Manager

NARROW

Improving immunotherapeutic efficacy against metastatic tumors in a pre-clinical model of murine renal cell carcinoma.

Dendritic cell CD40 targeting vaccines elicit CD8⁺ T cell-mediated therapeutic immunity against cancers

Blocking CD13 in combination with a toll like receptor agonist increases the efficacy of cancer vaccine adjuvants

Efficacy of combining radiotherapy and immunotherapy for metastatic colorectal cancer and the modulation of tumor microenvironment

Harnessing innate anti-tumour immunity using a Klebsiella-derived therapeutic to reduce tumour burden and improve outcomes in mouse models of lung cancer

Engineering of novel Class II Transactivator gene delivery systems as molecular adjuvants to improve genetic immunotherapies by inducing de novo MHC II expression in human cells

The cytotoxic formulation, INT230-6, induces protective T cell immunity

Genetic linkage analysis of cancer vaccine response in Diversity Outbred mice

Controlled release of mTOR inhibitors to enhance CD8⁺ T cell memory

Radiation Therapy and Talimogene Laherparepvec (TVEC) Synergize in the Treatment of Melanoma

Tumor Lysate Loaded Dendritic Cells Induce a T cell Specific Antitumor Response Against Gallbladder Cancer

CD11c⁺ MHCII^int bone marrow-derived dendritic cells as adjuvants for neoepitope – based cancer immunotherapy

RNAdjuvant^®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile

Pro-inflammatory properties of orally delivered calcium-encapsulated CpG Oligodeoxynucleotides

HER-2+ breast cancer cells expressing GPI-anchored cytokines induce long lasting antitumor memory response

Enhancement of antigen presentation of a vaccine with the use of human anti-rhamnose antibody both in-vitro and in-vivo

Analysis of immunogenicity of different sizes of HER2/neu antigen

Probing changes to local and systemic immunity following intranodal injection

New strategies in vaccine design for the induction of CD8 T cell responses using biodegradable iron oxide nanoparticles

Activation of the TLR2-MyD88 pathway is required for in-vivo efficacy of Lipid Nanoparticle based vaccine formulation

Publications

Submit a Manuscript

General Information

Journal Services

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only